Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients
Marcus Wiemer,1 Gian Battista Danzi,2 Nick West,3 Vassilios Voudris,4 René Koning,5 Stefan Hoffmann,6 Mario Lombardi,7 Josepa Mauri,8 Rade Babic,9 Fraser Witherow10On behalf of the NOBORI 2 Investigators 1Department of Cardiology, Heart and Diabetes Center North Rhine–Westphali...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/14e425105f1b4488962ea55d1d4aa157 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:14e425105f1b4488962ea55d1d4aa157 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:14e425105f1b4488962ea55d1d4aa1572021-12-02T00:47:37ZDrug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients1179-1470https://doaj.org/article/14e425105f1b4488962ea55d1d4aa1572015-02-01T00:00:00Zhttp://www.dovepress.com/drug-eluting-stents-with-biodegradable-polymer-for-the-treatment-of-pa-peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470 Marcus Wiemer,1 Gian Battista Danzi,2 Nick West,3 Vassilios Voudris,4 René Koning,5 Stefan Hoffmann,6 Mario Lombardi,7 Josepa Mauri,8 Rade Babic,9 Fraser Witherow10On behalf of the NOBORI 2 Investigators 1Department of Cardiology, Heart and Diabetes Center North Rhine–Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany; 2Ospedale Maggiore Policlinico, Milan, Italy; 3Papworth Hospital, Cambridge, UK; 4Onassis Cardiac Surgery Center, Athens, Greece; 5Clinique Saint Hilaire, Rouen, France; 6Vivantes Netzwerk für Gesundheit GmbH, Berlin, Germany; 7Azienda Ospedaliera Villa Sofia, Palermo, Italy; 8Hospital Universitari Germans Trias i Pujol, Badalona, Spain; 9Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia; 10Dorset County Hospital, Dorchester, UK Objective: This study investigates the safety and efficacy of a third-generation drug-eluting stent (DES) with biodegradable polymer in the complex patient population of diabetes mellitus (DM). Clinical trial registration: ISRCTN81649913. Background: Percutaneous coronary interventions in patients with DM are associated with a higher incidence of death, restenosis, and stent thrombosis as compared to non-diabetic patients. The use of a DES has been shown to improve outcomes in diabetic patients. Methods: Out of 3,067 patients, enrolled in 126 centers worldwide in the NOBORI 2 registry, 888 patients suffered from DM, 213 of them (14%) being insulin-dependent DM (IDDM). Two years’ follow-up has been completed in this study. Results: At 1- and 2-year follow-up, 97% and 95% of the patients, respectively, were available. The reported target lesion failure (TLF) rates at 1- and 2-year follow-up were 6.0% and 7.2% in the DM group, respectively, and 3.0% and 4.2% in the non-DM group, respectively (P<0.001 for both years). Inside the DM group, the TLF rates of 9.9% and 11.7% at the 1- and 2-year follow-ups, respectively, in patients with IDDM were significantly higher than the TLF rates of 4.7% and 5.8%, respectively, in the non-IDDM subgroup (P<0.01 for both years). The rate of stent thrombosis at the 2-year follow-up was 1.0% in the DM group and 0.7% in non-DM patients. There were no cases of late, or very late stent thrombosis in IDDM patients. Conclusion: The Nobori DES performed well in patients with DM. As expected, patients with DM, particularly those with IDDM, had worse outcomes. However, the absence of late, and very late stent thrombosis in IDDM patients merits further investigation, as this finding might have significant clinical value. Keywords: diabetes mellitus, percutaneous coronary intervention, biodegradable polymer, drug-eluting stentsWiemer MDanzi GBWest NVoudris VKoning RHoffmann SLombardi MMauri JBabic RWitherow FDove Medical PressarticleMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol 2015, Iss default, Pp 153-160 (2015) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medical technology R855-855.5 |
| spellingShingle |
Medical technology R855-855.5 Wiemer M Danzi GB West N Voudris V Koning R Hoffmann S Lombardi M Mauri J Babic R Witherow F Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients |
| description |
Marcus Wiemer,1 Gian Battista Danzi,2 Nick West,3 Vassilios Voudris,4 René Koning,5 Stefan Hoffmann,6 Mario Lombardi,7 Josepa Mauri,8 Rade Babic,9 Fraser Witherow10On behalf of the NOBORI 2 Investigators 1Department of Cardiology, Heart and Diabetes Center North Rhine–Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany; 2Ospedale Maggiore Policlinico, Milan, Italy; 3Papworth Hospital, Cambridge, UK; 4Onassis Cardiac Surgery Center, Athens, Greece; 5Clinique Saint Hilaire, Rouen, France; 6Vivantes Netzwerk für Gesundheit GmbH, Berlin, Germany; 7Azienda Ospedaliera Villa Sofia, Palermo, Italy; 8Hospital Universitari Germans Trias i Pujol, Badalona, Spain; 9Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia; 10Dorset County Hospital, Dorchester, UK Objective: This study investigates the safety and efficacy of a third-generation drug-eluting stent (DES) with biodegradable polymer in the complex patient population of diabetes mellitus (DM). Clinical trial registration: ISRCTN81649913. Background: Percutaneous coronary interventions in patients with DM are associated with a higher incidence of death, restenosis, and stent thrombosis as compared to non-diabetic patients. The use of a DES has been shown to improve outcomes in diabetic patients. Methods: Out of 3,067 patients, enrolled in 126 centers worldwide in the NOBORI 2 registry, 888 patients suffered from DM, 213 of them (14%) being insulin-dependent DM (IDDM). Two years’ follow-up has been completed in this study. Results: At 1- and 2-year follow-up, 97% and 95% of the patients, respectively, were available. The reported target lesion failure (TLF) rates at 1- and 2-year follow-up were 6.0% and 7.2% in the DM group, respectively, and 3.0% and 4.2% in the non-DM group, respectively (P<0.001 for both years). Inside the DM group, the TLF rates of 9.9% and 11.7% at the 1- and 2-year follow-ups, respectively, in patients with IDDM were significantly higher than the TLF rates of 4.7% and 5.8%, respectively, in the non-IDDM subgroup (P<0.01 for both years). The rate of stent thrombosis at the 2-year follow-up was 1.0% in the DM group and 0.7% in non-DM patients. There were no cases of late, or very late stent thrombosis in IDDM patients. Conclusion: The Nobori DES performed well in patients with DM. As expected, patients with DM, particularly those with IDDM, had worse outcomes. However, the absence of late, and very late stent thrombosis in IDDM patients merits further investigation, as this finding might have significant clinical value. Keywords: diabetes mellitus, percutaneous coronary intervention, biodegradable polymer, drug-eluting stents |
| format |
article |
| author |
Wiemer M Danzi GB West N Voudris V Koning R Hoffmann S Lombardi M Mauri J Babic R Witherow F |
| author_facet |
Wiemer M Danzi GB West N Voudris V Koning R Hoffmann S Lombardi M Mauri J Babic R Witherow F |
| author_sort |
Wiemer M |
| title |
Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients |
| title_short |
Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients |
| title_full |
Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients |
| title_fullStr |
Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients |
| title_full_unstemmed |
Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients |
| title_sort |
drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients |
| publisher |
Dove Medical Press |
| publishDate |
2015 |
| url |
https://doaj.org/article/14e425105f1b4488962ea55d1d4aa157 |
| work_keys_str_mv |
AT wiemerm drugelutingstentswithbiodegradablepolymerforthetreatmentofpatientswithdiabetesmellitusclinicaloutcomeat2yearsinalargepopulationofpatients AT danzigb drugelutingstentswithbiodegradablepolymerforthetreatmentofpatientswithdiabetesmellitusclinicaloutcomeat2yearsinalargepopulationofpatients AT westn drugelutingstentswithbiodegradablepolymerforthetreatmentofpatientswithdiabetesmellitusclinicaloutcomeat2yearsinalargepopulationofpatients AT voudrisv drugelutingstentswithbiodegradablepolymerforthetreatmentofpatientswithdiabetesmellitusclinicaloutcomeat2yearsinalargepopulationofpatients AT koningr drugelutingstentswithbiodegradablepolymerforthetreatmentofpatientswithdiabetesmellitusclinicaloutcomeat2yearsinalargepopulationofpatients AT hoffmanns drugelutingstentswithbiodegradablepolymerforthetreatmentofpatientswithdiabetesmellitusclinicaloutcomeat2yearsinalargepopulationofpatients AT lombardim drugelutingstentswithbiodegradablepolymerforthetreatmentofpatientswithdiabetesmellitusclinicaloutcomeat2yearsinalargepopulationofpatients AT maurij drugelutingstentswithbiodegradablepolymerforthetreatmentofpatientswithdiabetesmellitusclinicaloutcomeat2yearsinalargepopulationofpatients AT babicr drugelutingstentswithbiodegradablepolymerforthetreatmentofpatientswithdiabetesmellitusclinicaloutcomeat2yearsinalargepopulationofpatients AT witherowf drugelutingstentswithbiodegradablepolymerforthetreatmentofpatientswithdiabetesmellitusclinicaloutcomeat2yearsinalargepopulationofpatients |
| _version_ |
1718403478487826432 |